Positron Corporation POSC
1.72 USD +0.05 (+2.99%)
Nov 10, 2026, 3:34 PM EST
1.72 Day range 1.75
1.27 52-week range 2.74
- YTD
- +2.99%
- 1 year
- +8.86%
- Market cap
- 56.49M
- EPS (ttm)
- -0.33
- YTD return
- +2.99%
- 1-year return
- +8.86%
- Volume
- 2.70K
- Avg volume
- 17.80K
- Open
- 1.72
- Previous close
- 1.67
- Day's range
- 1.72 – 1.75
- 52-week range
- 1.27 – 2.74
- Earnings date
- Nov 30, 2019
No chart data for this range yet.
Next earnings
Nov 30, 2019
Expected Nov 30, 2019. Consensus EPS estimate 0.00.
Financials — quick view
POSC Revenue — quarterly 304.00K
POSC Net income — quarterly -255.00K
POSC EPS — quarterly -0.02
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 30, 2019 | Dec 1, 2013 | 0.00 | — | — | — |
| Nov 30, 2019 | Dec 1, 2010 | 0.00 | — | — | — |
| Nov 30, 2019 | Dec 1, 2012 | 0.00 | — | — | — |
News
Positron Corp. (OTCMKTS:POSC) Sees Significant Increase in Short Interest 
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET 
Head-To-Head Review: Positron (OTCMKTS:POSC) versus Pressure BioSciences (OTCMKTS:PBIO) 
Contrasting Positron (OTCMKTS:POSC) and AngioDynamics (NASDAQ:ANGO) 
Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices 
Reviewing Positron (OTCMKTS:POSC) and Tenon Medical (NASDAQ:TNON) 
OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review 
Positron Corporation Announces Its Transition to a Reporting SEC Company 
Positron Corporation Enters Industry Partnership Agreement with MedAxiom 
Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network's Excellence Awards 2025
Your note
Sign in to keep a note on POSC — it syncs with the Stock Master app.